NIKI

Niki BioSolutions, Inc. (NIKI) ESG Analysis Analysis (2026)

Invetso Score: 5.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.4 (Moderate)

No disclosed R&D intensity or emissions metrics are provided, limiting peer comparison on transition readiness versus more transparent industry peers.

The absence of capital-allocation data tied to environmental initiatives makes it harder to assess whether NIKI is ahead of peers on decarbonization execution.

Zero reported gross profit margin and missing FCF margin data constrain visibility into the funding capacity for environmental compliance relative to better-disclosed peers.

Low leverage suggests less balance-sheet pressure, which can support environmental capex flexibility versus more indebted peers, but it does not evidence superior environmental performance.

Social

Score:

No workforce, safety, turnover, or community metrics are disclosed, so NIKI cannot be credibly compared with peers on labor-management quality.

The absence of stock-based compensation data limits assessment of employee-alignment practices relative to peers that disclose broader incentive structures.

Missing operating cash-flow visibility reduces confidence in sustained investment in training, retention, and customer-service standards versus better-disclosed peers.

With no controversy or incident data provided, the social profile appears neutral, but disclosure depth remains weaker than that of leading peers.

Governance

Score:

Very low debt-to-equity and net debt-to-EBITDA indicate conservative leverage, which generally reduces creditor pressure and governance risk versus more levered peers.

Zero stock-based compensation to revenue suggests limited dilution pressure, but it also leaves incentive alignment harder to evaluate than at peers with fuller disclosure.

The lack of R&D and profitability disclosure weakens transparency around capital allocation oversight, making governance assessment less robust than for better-reporting peers.

No evidence of major governance controversy is provided, so the score is held above weak levels, though disclosure quality remains only average versus peers.

Overall Score

Score:

NIKI’s ESG positioning is broadly average versus peers, with conservative leverage supporting governance resilience, but limited disclosure materially constrains stronger relative scoring.

Score Driver: Limited ESG Disclosure Depth Versus Peers

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Niki BioSolutions, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →